mRNA Vaccine Cuts COVID-Related Guillain-Barré Risk

COVID-19 increases the risk for Guillain-Barré syndrome sixfold, while getting the Pfizer mRNA vaccine lowers risk.

Related Keywords

Arbel ,Ha Afon ,Israel ,Haya Bishara ,Eitan Auriel ,Medscape Coronavirus Resource Center ,Lady Davis Carmel Medical Center ,Boehringer Ingelheim ,Pfizer ,Israel Institute Of Technology ,Novo Nordisk ,Coronavirus Resource ,Anat Arbel ,Technion Israel Institute ,Lady Davis Carmel Medical ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Covid 19 Vaccine ,Coronavirus Vaccine ,Guillain Barre Syndrome ,Immunizations ,Vaccination ,Vaccine ,Biologic Therapy ,Antigens ,Hospitals ,Icd 10 ,Healthcare Technology ,Ealth Care Technology ,